Aggressive cutaneous malignancies following cardiothoracic transplantation: The Australian experience

Cancer

Volumn 85, Issue 8, 1999, Pages 1758-1764

  Veness, Michael J ^a   Quinn, David I ^b   Ong, Colin S ^c   Keogh, Anne M ^b   Macdonald, Peter S ^b   Cooper, Stephen G ^b   Morgan, Graeme W ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c SKIN AND CANCER FOUNDATION AUSTRALIA   (Australia)

Author keywords

Aggressive cutaneous malignancies; Cardiothothoracic transplant recipient; Radiotherapy

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; DISEASE DURATION; FEMALE; HEART LUNG TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR DIFFERENTIATION;

ADULT; AGED; AUSTRALIA; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HEART TRANSPLANTATION; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MELANOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, RADIATION-INDUCED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033560767     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990415)85:8<1758::AID-CNCR16>3.0.CO;2-F     Document Type: Article

References (21)

1. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993;7:431-45.
2. Penn I. Immunosuppression: a contributory factor in lymphoma formation. Clin Transplant 1992;6:214-9.
3. Keogh A, Kaan A, McCosker C. The Australian and New Zealand Cardiothoracic Organ Transplant Registry. 6th annual report, 1984-1996. 1996.
4. Euvrard S, Kanitakis J, Pouteil-Noble C, Distant F, Dureau G, Finaz de Villaine J, et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995;27: 1767-8.
5. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106-12.
6. Sheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993;25:1383-4.
7. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49:506-9.
8. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant. Lancet 1995;346:403-6.
9. Marks R, Staples M, Giles GG. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993;53:585-90.
10. Jelfs PL, Giles G, Shugg D, Coates M, Durling G, Fitzgerald P, et al. Cutaneous malignant melanoma in Australia, 1989. Med J Aust 1994;161:182-7.
11. Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC. Cancer, warts, and sunshine in renal transplant patients: a case-control study. Lancet 1984;1:702-5.
12. Penn I. Malignancy. Surg Clin North Am 1994;74:1247-57.
13. Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989;1:124-9.
14. Soler C, Chardonnet Y, Allibert P, Euvrard S, Schmitt D, Mandrand B. Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. J Invest Dermatol 1993;101:286-91.
15. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of of human papilloma viruses. Papilloma viruses. Wiley, Ciba Foundation Symposium 1986; 120:157-74.
16. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995;33:690-5.
17. Penn I. Cancers in cyclosporine-treated vs. azathioprine-treated patients. Transplant Proc 1996;28:876-8.
18. Keogh A, Macdonald P, Harvison A, Richens D, Mundy J, Spratt P. Initial steroid-free versus steroid based maintenance therapy, and steroid withdrawal after cardiac transplantation: two views of the steroid question. J Heart Lung Transplant 1992;11:421-7.
19. Trush MA, Mimnaugh EG, Gram TE. Activation of pharmacological agents to radical intermediates: implications for the role free radicals in drug action and toxicity. Biochem Pharmacol 1982;31:3335-46.
20. Sheil AGR. Development of malignancy following renal transplantation in Australia and New Zealand. Transplant Proc 1992;24:1275-9.
21. Ong CS, Keogh AM, Kossard S, Macdonald PS, Spratt PM. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1998. In press.